The U.S. government has invested more than $5 billion in COVID-19 vaccines, creating a race to the finish line in the Biopharma industry, many of which rely on ‘made in the USA’ Aeroturn high performance turnstiles to secure against unauthorized access to their facilities, and protect themselves from situations emanating from corporate espionage, vaccine protestors, product tampering, and leaked information.